NO2820009T3 - - Google Patents

Info

Publication number
NO2820009T3
NO2820009T3 NO13710222A NO13710222A NO2820009T3 NO 2820009 T3 NO2820009 T3 NO 2820009T3 NO 13710222 A NO13710222 A NO 13710222A NO 13710222 A NO13710222 A NO 13710222A NO 2820009 T3 NO2820009 T3 NO 2820009T3
Authority
NO
Norway
Application number
NO13710222A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47296498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2820009(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2820009T3 publication Critical patent/NO2820009T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/62—Use of additives, e.g. for stabilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/297—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/593—Dicarboxylic acid esters having only one carbon-to-carbon double bond
    • C07C69/60—Maleic acid esters; Fumaric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/604—Polycarboxylic acid esters, the acid moiety containing more than two carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO13710222A 2011-06-08 2013-03-01 NO2820009T3 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161494775P 2011-06-08 2011-06-08

Publications (1)

Publication Number Publication Date
NO2820009T3 true NO2820009T3 (https=) 2018-06-30

Family

ID=47296498

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13710222A NO2820009T3 (https=) 2011-06-08 2013-03-01

Country Status (32)

Country Link
US (1) US9422226B2 (https=)
EP (1) EP2718257B1 (https=)
JP (3) JP6385273B6 (https=)
KR (2) KR20150080037A (https=)
CN (1) CN103649041A (https=)
AU (1) AU2012267524A1 (https=)
BR (1) BR112013031616A2 (https=)
CA (1) CA2838271A1 (https=)
CL (1) CL2013003483A1 (https=)
CO (1) CO6821956A2 (https=)
CY (1) CY1119920T1 (https=)
DK (1) DK2718257T3 (https=)
EA (1) EA201391638A1 (https=)
EC (1) ECSP14013123A (https=)
ES (1) ES2659771T3 (https=)
HR (1) HRP20180203T1 (https=)
HU (1) HUE036085T2 (https=)
IL (1) IL229656A0 (https=)
LT (1) LT2718257T (https=)
ME (1) ME02960B (https=)
MX (1) MX355421B (https=)
NO (1) NO2820009T3 (https=)
NZ (1) NZ618178A (https=)
PE (1) PE20141639A1 (https=)
PH (1) PH12013502498A1 (https=)
PL (1) PL2718257T3 (https=)
PT (1) PT2718257T (https=)
RS (1) RS56972B1 (https=)
SG (1) SG195227A1 (https=)
SI (1) SI2718257T1 (https=)
SM (1) SMT201800098T1 (https=)
WO (1) WO2012170923A1 (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1663197T1 (sl) 2003-09-09 2008-06-30 Biogen Idec Internat Gmbh Uporaba derivatov fumarne kisline za zdravljenje sräśne insuficience in astme
LT2801354T (lt) 2004-10-08 2017-06-26 Forward Pharma A/S Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį
HRP20140640T1 (hr) 2008-08-19 2014-11-21 Xenoport, Inc. Prolijekovi monometil estera fumarne kiseline, farmaceutski sastavi iz toga i postupci njihove uporabe
SMT201800098T1 (it) 2011-06-08 2018-03-08 Biogen Ma Inc Processo per la preparazione di dimetilfumarato cristallino e con purezza elevata
AU2013305684B2 (en) 2012-08-22 2016-11-24 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
US10945984B2 (en) 2012-08-22 2021-03-16 Arbor Pharmaceuticals, Llc Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
AR094277A1 (es) 2012-12-21 2015-07-22 Biogen Idec Inc Derivados de fumarato sustituidos con deuterio
BR112015022854A2 (pt) 2013-03-14 2017-07-18 Alkermes Pharma Ireland Ltd pró-farmacos de fumaratos e uso do mesmo no tratamento de várias doenças
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
WO2014160633A1 (en) 2013-03-24 2014-10-02 Xenoport, Inc. Pharmaceutical compositions of dimethyl fumarate
CN104098471A (zh) * 2013-04-03 2014-10-15 南京卡文迪许生物工程技术有限公司 富马酸二甲酯多晶型物及其制备方法和药物组合物
WO2014197860A1 (en) 2013-06-07 2014-12-11 Xenoport, Inc. Method of making monomethyl fumarate
WO2014205392A1 (en) 2013-06-21 2014-12-24 Xenoport, Inc. Cocrystals of dimethyl fumarate
EP3041467A1 (en) 2013-09-06 2016-07-13 XenoPort, Inc. Crystalline forms of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate, methods of synthesis and use
IN2013MU03070A (https=) * 2013-09-25 2015-07-17 Glenmark Pharmaceuticals Ltd
EP3097075A4 (en) * 2014-01-24 2017-06-21 Shilpa Medicare Limited Process for preparation of dimethyl-(e)-butenedioate
JP6337135B2 (ja) 2014-02-24 2018-06-06 アルカーメス ファーマ アイルランド リミテッド フマル酸エステルのスルホンアミドプロドラッグ及びスルフィンアミドプロドラッグ並びに種々の疾患の治療におけるその使用
AU2015222880B2 (en) 2014-02-28 2016-11-24 Banner Life Sciences Llc Controlled release enteric soft capsules of fumarate esters
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US10626076B2 (en) * 2014-03-17 2020-04-21 Biophore India Pharmaeuticals Pvt. Ltd. Process for the synthesis of dimethyl fumarate
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
EP3164378A1 (en) * 2014-07-03 2017-05-10 Synthon B.V. Process for making microcrystalline dimethyl fumarate
CN104151165B (zh) * 2014-08-11 2016-08-24 广东东阳光药业有限公司 制备富马酸二甲酯的方法
CN104761453A (zh) * 2015-04-22 2015-07-08 河南中帅医药科技股份有限公司 一种富马酸二甲酯晶型及其制备方法
CA2987895A1 (en) * 2015-06-01 2016-12-08 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
MX387092B (es) 2015-06-17 2025-03-19 Biogen Ma Inc Particulas de dimetilfumarato y composiciones farmaceuticas de estas.
CN106316841A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种富马酸二甲酯的制备方法
WO2017013672A1 (en) * 2015-07-23 2017-01-26 Natco Pharma Ltd Process for the preparation of pharmaceutical grade dimethyl fumarate
US10011663B2 (en) 2016-02-04 2018-07-03 Eastman Chemical Company Vulcanizing composition containing cyclododecasulfur and improved cyclododecasulfur compound
RU2616605C1 (ru) * 2016-04-07 2017-04-18 Олег Ростиславович Михайлов Кристаллическая бета - модификация (Е)-диметилбутендиоата, способ её получения и фармацевтическая композиция на её основе
CN107285320A (zh) * 2017-08-02 2017-10-24 内蒙古新福地科技有限公司 一种氟硅酸钠的结晶方法及装置
JP7153069B2 (ja) * 2017-10-10 2022-10-13 ファイザー・インク ロルラチニブ遊離塩基水和物の結晶形態
US11903918B2 (en) 2020-01-10 2024-02-20 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability
KR102271575B1 (ko) * 2020-09-16 2021-07-01 김갑용 염의 이온교환법을 이용한 친환경 고효율 에스터화반응 기반의 에스터화합물 제조방법 및 이의 화합물
JP6865489B1 (ja) * 2020-10-20 2021-04-28 株式会社エス・ディー・エス バイオテック ２，３，５，６−テトラクロロ−１，４−ベンゼンジカルボン酸ジメチルの製造方法
CN117550970A (zh) * 2023-10-30 2024-02-13 寿光金远东变性淀粉有限公司 一种高纯度衣康酸二甲酯的生产方法

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1848724A (en) * 1932-03-08 Alphons
US2764609A (en) * 1953-07-24 1956-09-25 Monsanto Chemicals Isomerization of dialkyl maleates to dialkyl fumarates
US3078302A (en) * 1958-09-25 1963-02-19 Monsanto Chemicals Production of dialkyl fumarates
US3993684A (en) 1971-08-20 1976-11-23 Western Litho Plate & Supply Co. Monomeric compounds
US4417062A (en) 1976-09-24 1983-11-22 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4239636A (en) 1978-10-23 1980-12-16 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4866187A (en) 1976-09-24 1989-09-12 Exxon Research & Engineering Company Thio-bis(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4965375A (en) 1976-09-24 1990-10-23 Exxon Research And Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US5118835A (en) 1976-09-24 1992-06-02 Exxon Research & Engineering Co. Thio-bis(alkyl lactone acid esters) and thio-bis (Hydrocarbyl diacid esters) are usefull additives for lubricating compositions
US4568756A (en) 1976-09-24 1986-02-04 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
JPS60193946U (ja) 1984-03-01 1985-12-24 内山　茂夫 変色炎を有するろうそく
JPS60193946A (ja) * 1984-03-16 1985-10-02 Nippon Oil & Fats Co Ltd ジイソプロピルフマレ−トの製造法
US5149695A (en) 1985-01-15 1992-09-22 Speiser Peter P Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same
CH664150A5 (de) 1985-01-15 1988-02-15 Peter Paul Prof Dr Speiser Fumarsaeureprodrug, verfahren zu seiner herstellung und dieses enthaltende darreichungsformen.
JPS61246147A (ja) * 1985-04-22 1986-11-01 Nippon Shokubai Kagaku Kogyo Co Ltd マレイン酸ジアルキルエステルの精製方法
US4963275A (en) 1986-10-07 1990-10-16 Exxon Chemical Patents Inc. Dispersant additives derived from lactone modified amido-amine adducts
US4954276A (en) 1986-10-07 1990-09-04 Exxon Chemical Patents Inc. Lactone modified adducts or reactants and oleaginous compositions containing same
US5032320A (en) 1986-10-07 1991-07-16 Exxon Chemical Patents Inc. Lactone modified mono- or dicarboxylic acid based adduct dispersant compositions
US4866139A (en) 1986-10-07 1989-09-12 Exxon Chemical Patents Inc. Lactone modified, esterified dispersant additives useful in oleaginous compositions
US4866140A (en) 1986-10-07 1989-09-12 Exxon Chemical Patents Inc. Lactone modified adducts or reactants and oleaginous compositions containing same
US4954277A (en) 1986-10-07 1990-09-04 Exxon Chemical Patents Inc. Lactone modified, esterified or aminated additives useful in oleaginous compositions and compositions containing same
US4906394A (en) 1986-10-07 1990-03-06 Exxon Chemical Patents Inc. Lactone modified mono-or dicarboxylic acid based adduct dispersant compositions
DE3711155A1 (de) 1987-04-02 1988-10-13 Bayer Ag Verfahren zur herstellung von maleinsaeuredimethylester
US4971711A (en) 1987-07-24 1990-11-20 Exxon Chemical Patents, Inc. Lactone-modified, mannich base dispersant additives useful in oleaginous compositions
US4820432A (en) 1987-07-24 1989-04-11 Exxon Chemical Patents Inc. Lactone-modified, Mannich base dispersant additives useful in oleaginous compositions
US5424332A (en) 1987-10-19 1995-06-13 Speiser; Peter P. Pharmaceutical composition and process for the production thereof
US4959389A (en) 1987-10-19 1990-09-25 Speiser Peter P Pharmaceutical preparation for the treatment of psoriatic arthritis
US4943382A (en) 1988-04-06 1990-07-24 Exxon Chemical Patents Inc. Lactone modified dispersant additives useful in oleaginous compositions
US5153352A (en) 1988-10-25 1992-10-06 Bristol-Myers Squibb Company Process for preparation of intermediates of carbocyclic nucleoside analogs
ATE154365T1 (de) 1993-01-21 1997-06-15 Akzo Nobel Nv Lufttrocknende wässrige polymerdispersionen
CN1103398A (zh) 1993-11-30 1995-06-07 张治明 一种由顺酐生产富马酸二甲酯的工艺方法
DE19581851T1 (de) 1994-11-21 1998-02-12 Asahi Chemical Ind Härtbares Harz und dieses enthaltende Harzzusammensetzung
WO1997049685A1 (en) 1996-06-24 1997-12-31 Cytec Technology Corp. Polymerizable urea/ureido functional monomers
US6239189B1 (en) 1997-04-01 2001-05-29 Henkel Corporation Radiation-polymerizable composition and printing inks containing same
DE19721099C2 (de) 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
CA2265844C (en) 1997-07-11 2007-10-30 Showa Denko K.K. New ether compounds and process for producing the same
US6376702B1 (en) 1997-07-11 2002-04-23 Showa Denko K.K. Ether compound, production thereof and curable compositions
GB9724004D0 (en) 1997-11-13 1998-10-21 Kvaerner Process Tech Ltd Process
DE19814358C2 (de) 1998-03-31 2002-01-17 Fumapharm Ag Muri Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn
DE19839566C2 (de) 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
DE19848260C2 (de) 1998-10-20 2002-01-17 Fumapharm Ag Muri Fumarsäure-Mikrotabletten
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
DE10084257B4 (de) 1999-12-27 2007-03-29 Asahi Kasei Kabushiki Kaisha Polyoxymethylen-Harzzusammensetzung
DE10000577A1 (de) 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
AU3228301A (en) 2000-02-15 2001-08-27 Showa Denko Kabushiki Kaisha Process for producing fumaric ester
JP2001281800A (ja) 2000-03-31 2001-10-10 Konica Corp 熱現像写真感光材料
US6586452B1 (en) 2000-07-14 2003-07-01 Merck & Co., Inc. C1 to C4 side chain modified nodulisporic acid analogs
US20020098451A1 (en) 2000-09-07 2002-07-25 Tadashi Arimoto Photothermographic material
DE10101307A1 (de) 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
HU230252B1 (hu) 2001-01-12 2015-11-30 Biogen Idec International Gmbh Fumársav-amid származékok
JP2003160535A (ja) * 2001-11-28 2003-06-03 Nof Corp 不飽和二塩基酸ジエステルの製造方法
EP1867626A3 (en) 2002-02-28 2008-07-23 Sumitomo Chemical Company, Limited Process for producing chromone compound
DE10217314A1 (de) 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
JP2003315960A (ja) 2002-04-25 2003-11-06 Konica Minolta Holdings Inc 銀塩光熱写真ドライイメージング材料
JP4259815B2 (ja) 2002-06-06 2009-04-30 ダイセル化学工業株式会社 高純度酢酸ブチルの製造方法
SI1663197T1 (sl) 2003-09-09 2008-06-30 Biogen Idec Internat Gmbh Uporaba derivatov fumarne kisline za zdravljenje sräśne insuficience in astme
JP4163653B2 (ja) 2004-02-27 2008-10-08 株式会社日本触媒 光学部品用硬化性組成物
WO2007087815A2 (en) 2004-12-17 2007-08-09 Metanomics Gmbh Process for the control of production of fine chemicals
US7557241B2 (en) 2004-08-30 2009-07-07 Sanyo Chemical Industries, Ltd. Method for producing α,β-unsaturated carboxylic acid ester, α,β-unsaturated carboxylic acid ester, and lubricating oil additive
LT2801354T (lt) 2004-10-08 2017-06-26 Forward Pharma A/S Kontroliuojamo atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį
TWI279403B (en) 2004-10-20 2007-04-21 Eternal Chemical Co Ltd Cyclobutanetetracarboxylate compound and preparation method thereof
EP1812374A1 (en) 2004-11-10 2007-08-01 Aditech Pharma AB Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
DE602005018115D1 (de) 2005-04-22 2010-01-14 Canon Kk Magnetischer toner
DE102005022845A1 (de) 2005-05-18 2006-11-23 Fumapharm Ag Thiobernsteinsäurederivate und deren Verwendung
EP1915334A2 (en) 2005-07-07 2008-04-30 Aditech Pharma AB Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
TW200707103A (en) 2005-08-12 2007-02-16 Lion Corp Photoresist polymer having nanosmoothness and etching resistance and resist composition
WO2007042035A2 (en) 2005-10-07 2007-04-19 Aditech Pharma Ab Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
US20080299196A1 (en) 2005-10-07 2008-12-04 Aditech Pharma Ab Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
AU2006344611A1 (en) 2006-06-16 2007-12-21 Gumlink A/S Chewing gum comprising a hydrophobic enzyme formulation
SI2139467T1 (sl) 2007-02-08 2017-01-31 Biogen Ma Inc. Zaščita živčevja pri demielinizacijskih obolenjih
EP2680006A1 (en) 2007-02-08 2014-01-01 Biogen Idec MA Inc. Treatment for Amyotrophic Lateral Sclerosis
WO2009045637A2 (en) 2007-08-10 2009-04-09 Genomatica, Inc. Methods for the synthesis of acrylic acid and derivatives from fumaric acid
EP2219783B1 (en) 2007-10-26 2017-10-11 Purolite International, Ltd. Controlled catalysis
US8318893B2 (en) 2007-12-12 2012-11-27 Mitsubishi Chemical Corporation Aliphatic polyester resin and its production method
WO2010079222A1 (en) 2009-01-09 2010-07-15 Forward Pharma A/S Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
US20120165404A1 (en) 2009-04-29 2012-06-28 Biogen Idec Ma Inc. Treatment of neurodegeneration and neuroinflammation
CN102471218B (zh) 2009-08-07 2014-11-05 因温斯特技术公司 用于形成二酯的氢化并酯化
HUE025878T2 (en) 2010-02-12 2016-05-30 Biogen Ma Inc Neuroprotection in demyelinating diseases
CN102757346A (zh) 2011-04-26 2012-10-31 中国科学院兰州化学物理研究所 一种富马酸二甲酯的制备方法
AU2012258558A1 (en) 2011-05-26 2013-05-02 Biogen Ma Inc. Methods of treating multiple sclerosis and preserving and/or increasing myelin content
SMT201800098T1 (it) 2011-06-08 2018-03-08 Biogen Ma Inc Processo per la preparazione di dimetilfumarato cristallino e con purezza elevata
CN102432464A (zh) 2011-12-14 2012-05-02 费近峰 一种富马酸二甲酯的连续生产工艺
NZ627980A (en) 2012-02-07 2016-12-23 Biogen Ma Inc Pharmaceutical compositions containing dimethyl fumarate
CN102766050A (zh) 2012-08-10 2012-11-07 太仓市运通化工厂 一种富马酸二甲酯的合成方法
AR094277A1 (es) 2012-12-21 2015-07-22 Biogen Idec Inc Derivados de fumarato sustituidos con deuterio
CN103848739A (zh) 2014-03-20 2014-06-11 徐晓宁 一种高纯度富马酸二甲酯的生产方法

Also Published As

Publication number Publication date
RS56972B1 (sr) 2018-05-31
EP2718257B1 (en) 2017-11-15
WO2012170923A1 (en) 2012-12-13
DK2718257T3 (en) 2018-02-12
JP2014522413A (ja) 2014-09-04
ES2659771T3 (es) 2018-03-19
EA201391638A1 (ru) 2014-05-30
ECSP14013123A (es) 2014-06-30
ME02960B (me) 2018-07-20
NZ618178A (en) 2016-03-31
JP6385273B2 (ja) 2018-09-05
SI2718257T1 (en) 2018-04-30
HRP20180203T1 (hr) 2018-04-06
SG195227A1 (en) 2013-12-30
JP6385273B6 (ja) 2023-12-15
KR20150080037A (ko) 2015-07-08
US20140200363A1 (en) 2014-07-17
CO6821956A2 (es) 2013-12-31
PT2718257T (pt) 2018-02-26
KR20140035995A (ko) 2014-03-24
EP2718257A4 (en) 2015-08-12
US9422226B2 (en) 2016-08-23
PE20141639A1 (es) 2014-11-08
EP2718257A1 (en) 2014-04-16
LT2718257T (lt) 2018-03-12
PL2718257T3 (pl) 2018-04-30
MX355421B (es) 2018-04-18
SMT201800098T1 (it) 2018-03-08
BR112013031616A2 (pt) 2016-12-06
IL229656A0 (en) 2014-01-30
JP2018162266A (ja) 2018-10-18
PH12013502498A1 (en) 2014-01-20
HUE036085T2 (hu) 2018-06-28
JP2016155868A (ja) 2016-09-01
CA2838271A1 (en) 2012-12-13
CL2013003483A1 (es) 2014-05-09
MX2013014320A (es) 2014-01-31
CY1119920T1 (el) 2018-06-27
AU2012267524A1 (en) 2013-12-12
CN103649041A (zh) 2014-03-19

Similar Documents

Publication Publication Date Title
BR112013022641A2 (https=)
BR112013031251A2 (https=)
BR112013023185A2 (https=)
BR112013022995A2 (https=)
BR112013017670A2 (https=)
BR112013027830A2 (https=)
BR112013026744A2 (https=)
AP3853A (https=)
NO2820009T3 (https=)
BR112013023927A2 (https=)
BR112013024365A2 (https=)
BR112013028733A2 (https=)
BR112013027121A2 (https=)
AP2016009466A0 (https=)
BR112013031556A2 (https=)
BR112013032368A2 (https=)
BR112013032380A2 (https=)
BR112013032377A2 (https=)
BR112013027836A2 (https=)
BR112013018949A2 (https=)
BR112013027761A2 (https=)
BR112013021637A2 (https=)
BR112013025487A2 (https=)
BR112013023266A2 (https=)
BR112013032392A2 (https=)